CMPX
Price
$3.18
Change
+$0.48 (+17.78%)
Updated
Aug 11, 12:56 PM (EDT)
Capitalization
373.36M
Earnings call today
CPRX
Price
$19.89
Change
+$0.03 (+0.15%)
Updated
Aug 11, 01:01 PM (EDT)
Capitalization
2.43B
86 days until earnings call
Interact to see
Advertisement

CMPX vs CPRX

Header iconCMPX vs CPRX Comparison
Open Charts CMPX vs CPRXBanner chart's image
Compass Therapeutics
Price$3.18
Change+$0.48 (+17.78%)
Volume$623
Capitalization373.36M
Catalyst Pharmaceuticals
Price$19.89
Change+$0.03 (+0.15%)
Volume$1.78K
Capitalization2.43B
CMPX vs CPRX Comparison Chart in %
Loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMPX vs. CPRX commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Hold and CPRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (CMPX: $2.70 vs. CPRX: $19.86)
Brand notoriety: CMPX and CPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 74% vs. CPRX: 157%
Market capitalization -- CMPX: $373.36M vs. CPRX: $2.43B
CMPX [@Biotechnology] is valued at $373.36M. CPRX’s [@Biotechnology] market capitalization is $2.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 0 FA rating(s) are green whileCPRX’s FA Score has 1 green FA rating(s).

  • CMPX’s FA Score: 0 green, 5 red.
  • CPRX’s FA Score: 1 green, 4 red.
According to our system of comparison, CPRX is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 4 TA indicator(s) are bullish while CPRX’s TA Score has 3 bullish TA indicator(s).

  • CMPX’s TA Score: 4 bullish, 4 bearish.
  • CPRX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CMPX is a better buy in the short-term than CPRX.

Price Growth

CMPX (@Biotechnology) experienced а -8.47% price change this week, while CPRX (@Biotechnology) price change was -5.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.49%. For the same industry, the average monthly price growth was +31.98%, and the average quarterly price growth was +19.31%.

Reported Earning Dates

CMPX is expected to report earnings on Aug 11, 2025.

CPRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+22.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPRX($2.43B) has a higher market cap than CMPX($373M). CMPX YTD gains are higher at: 86.207 vs. CPRX (-4.839). CPRX has higher annual earnings (EBITDA): 269M vs. CMPX (-60.17M). CPRX has more cash in the bank: 581M vs. CMPX (113M). CPRX has less debt than CMPX: CPRX (3.09M) vs CMPX (6.38M). CPRX has higher revenues than CMPX: CPRX (535M) vs CMPX (850K).
CMPXCPRXCMPX / CPRX
Capitalization373M2.43B15%
EBITDA-60.17M269M-22%
Gain YTD86.207-4.839-1,781%
P/E RatioN/A12.04-
Revenue850K535M0%
Total Cash113M581M19%
Total Debt6.38M3.09M206%
FUNDAMENTALS RATINGS
CPRX: Fundamental Ratings
CPRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
28
SMR RATING
1..100
34
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMPXCPRX
RSI
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
73%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
63%
Advances
ODDS (%)
Bullish Trend 15 days ago
88%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 5 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APTTF0.07N/A
N/A
Asian Pay Television Trust
JSNSF4.03N/A
N/A
J Sainsbury plc
MNHFF72.00N/A
N/A
Mayr-Melnhof Karton AG
PLLWF0.01N/A
N/A
Polarean Imaging Ltd.
RREMX15.44-0.05
-0.32%
RBC Emerging Markets Equity R6

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VIR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-7.22%
VIR - CMPX
40%
Loosely correlated
-1.15%
CPRX - CMPX
37%
Loosely correlated
+1.15%
MGNX - CMPX
35%
Loosely correlated
-4.35%
SANA - CMPX
34%
Loosely correlated
-29.41%
FHTX - CMPX
34%
Loosely correlated
-8.03%
More

CPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with VIR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
+1.15%
VIR - CPRX
47%
Loosely correlated
-1.15%
LGND - CPRX
46%
Loosely correlated
+2.56%
SANA - CPRX
45%
Loosely correlated
-29.41%
CRNX - CPRX
45%
Loosely correlated
-3.69%
SYRE - CPRX
41%
Loosely correlated
N/A
More